BIPIX
Price
$37.82
Change
+$1.24 (+3.39%)
Updated
Apr 24 closing price
Net Assets
62.06M
RYVLX
Price
$435.49
Change
+$23.07 (+5.59%)
Updated
Apr 24 closing price
Net Assets
585.4M
Ad is loading...

BIPIX vs RYVLX

Header iconBIPIX vs RYVLX Comparison
Open Charts BIPIX vs RYVLXBanner chart's image
ProFunds Biotechnology UltraSector I
Price$37.82
Change+$1.24 (+3.39%)
VolumeN/A
Net Assets62.06M
Rydex NASDAQ-100® 2x Strategy A
Price$435.49
Change+$23.07 (+5.59%)
VolumeN/A
Net Assets585.4M
BIPIX vs RYVLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BIPIX vs. RYVLX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIPIX is a Buy and RYVLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 585M vs. BIPIX (62.1M). BIPIX pays higher dividends than RYVLX: BIPIX (0.20) vs RYVLX (0.00). BIPIX was incepted earlier than RYVLX: BIPIX (25 years) vs RYVLX (21 years). RYVLX (2.01) is less costly to investors than BIPIX (1.56). RYVLX is a more actively managed with annual turnover of: 392.00 vs. BIPIX (196.00). RYVLX has a lower initial minimum investment than BIPIX: RYVLX (2500) vs BIPIX (15000). RYVLX annual gain was more profitable for investors over the last year : -4.36 vs. BIPIX (-36.02). RYVLX return over 5 years is better than : 133.76 vs. BIPIX (-44.74).
BIPIXRYVLXBIPIX / RYVLX
Total Expense Ratio1.561.9082%
Annual Report Gross Expense Ratio1.562.0178%
Fund Existence25 years21 years-
Gain YTD-21.998-25.09288%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets62.1M585M11%
Annual Yield % from dividends0.200.00-
Returns for 1 year-36.02-4.36826%
Returns for 3 years-38.6229.18-132%
Returns for 5 years-44.74133.76-33%
Returns for 10 years-51.21413.10-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DIEQX33.430.49
+1.49%
Domini Impact Equity Institutional
MCTOX11.18N/A
N/A
Modern Capital Tactical Income A
SPIDX56.70N/A
N/A
Invesco S&P 500 Index Y
VPMCX147.10N/A
N/A
Vanguard PRIMECAP Inv
LCBDX22.78N/A
N/A
ClearBridge Tactical Dividend Income IS